Drospirenone/Ethinyl Estradiol 3 Mg/20 &Micro;g (24/4 Day Regimen): Hormonal Contraceptive Choices &Ndash; Use of a Fourth-Generation Progestin

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s3901
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search